Why Can Liver Cancer Occur With a Normal AFP?

HCC Screening

Blog Why Can Liver Cancer Occur With a Normal AFP? A normal alpha-fetoprotein (AFP) blood test can be reassuring—but it does not necessarily mean that liver cancer is absent. Hepatocellular carcinoma (HCC), the most common form of primary liver cancer, is biologically diverse. Some HCC tumors produce enough AFP to raise its concentration in the […]

How Fusion Transcripts Are Changing Blood-Based Liver Cancer Detection?

Blood-Based-Liver-Cancer-Detection

Blog How Fusion Transcripts Are Changing Blood-Based Liver Cancer Detection? Cancer begins with molecular changes. Some of those changes alter the structure of chromosomes, bringing together genetic material that normally exists in separate locations. The result can be a fusion gene—and when that altered gene is expressed, it can produce a distinctive fusion transcript. For […]

Can a Blood Test Help Detect Liver Cancer Early?

Early Liver Cancer Detection

Blog Can a Blood Test Help Detect Liver Cancer Early? Liver cancer can develop quietly. Hepatocellular carcinoma (HCC), the most common form of primary liver cancer, may cause few noticeable symptoms during its early stages. For people at increased risk, this makes regular surveillance particularly important. Blood testing can provide useful information, but not all […]

Why Liver Cancer Screening Needs Better Blood-Based Options?

Liver-cancer-screening

Blog Why Liver Cancer Screening Needs Better Blood-Based Options? Hepatocellular carcinoma (HCC), the most common form of primary liver cancer, presents an unusual challenge: the disease can develop and progress without obvious symptoms. For people at increased risk, detecting HCC early can make an important difference because more treatment options are available when disease is […]

Beyond AFP: The Next Generation of Liver Cancer Blood Testing

Liver Cancer Blood Testing

Blog Beyond AFP: The Next Generation of Liver Cancer Blood Testing Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer. One of the major challenges in HCC is that early disease may cause few or no symptoms. Yet early detection matters because patients with localized disease have substantially more treatment options than […]